Shopping Cart
- Remove All
- Your shopping cart is currently empty
CDFI is a lipid II flipase (MurJ) inhibitor that inhibits methicillin-resistant Staphylococcus aureus (MRSA) cell wall biosynthesis, used in the study of MRSA infections.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $143 | In Stock | |
5 mg | $359 | In Stock | |
10 mg | $579 | In Stock | |
25 mg | $1,160 | In Stock | |
50 mg | $1,560 | In Stock | |
100 mg | $2,080 | In Stock |
Description | CDFI is a lipid II flipase (MurJ) inhibitor that inhibits methicillin-resistant Staphylococcus aureus (MRSA) cell wall biosynthesis, used in the study of MRSA infections. |
In vitro | CDFI is a novel anti-infective agent targeting MRSA cell wall biosynthesis. [1] |
Molecular Weight | 446.99 |
Formula | C28H28ClFN2 |
Cas No. | 1199797-92-6 |
Smiles | FC=1C=CC=2NC(C=3C=CC=CC3Cl)=C(C2C1)C4CCN(CC=5C=CC=C(C5C)C)CC4 |
Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 80 mg/mL (178.97 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.